Literature DB >> 29391906

PERCIST in Perspective.

Joo Hyun O1, Richard L Wahl2.   

Abstract

Positron Emission tomography Response Criteria In Solid Tumors (PERCIST) version 1.0 was introduced in 2009 for objective assessment of tumor metabolic response using 18F-FDG PET/CT. Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0 was published in 2016 to review and clarify some of the issues with the PERCIST. In this article, we reflect on the benefits and challenges of implementing PERCIST, and speculate on topics that could be discussed in PERCIST 1.1 in the future.

Entities:  

Year:  2017        PMID： 29391906      PMCID： PMC5777964          DOI： 10.1007/s13139-017-0507-4

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


  18 in total

1.  Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

Authors:  Bruce D Cheson; Richard I Fisher; Sally F Barrington; Franco Cavalli; Lawrence H Schwartz; Emanuele Zucca; T Andrew Lister
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

2.  Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer.

Authors:  Sae-Ryung Kang; Ho-Chun Song; Byung Hyun Byun; Jong-Ryool Oh; Hyeon-Sik Kim; Sun-Pyo Hong; Seong Young Kwon; Ari Chong; Jahae Kim; Sang-Geon Cho; Hee Jeong Park; Young-Chul Kim; Sung-Ja Ahn; Jung-Joon Min; Hee-Seung Bom
Journal:  Nucl Med Mol Imaging       Date:  2013-09-06

3.  Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer.

Authors:  Christopher C Riedl; Katja Pinker; Gary A Ulaner; Leonard T Ong; Pascal Baltzer; Maxine S Jochelson; Heather L McArthur; Mithat Gönen; Maura Dickler; Wolfgang A Weber
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-01       Impact factor: 9.236

4.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Authors:  H Young; R Baum; U Cremerius; K Herholz; O Hoekstra; A A Lammertsma; J Pruim; P Price
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

5.  Prognostic Significance of Intratumoral Metabolic Heterogeneity on 18F-FDG PET/CT in Pathological N0 Non-Small Cell Lung Cancer.

Authors:  Do-Hoon Kim; Ji-Hoon Jung; Seung Hyun Son; Choon-Young Kim; Chae Moon Hong; Jong-Ryool Oh; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Clin Nucl Med       Date:  2015-09       Impact factor: 7.794

6.  Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy.

Authors:  Heather A Jacene; Sophie Leboulleux; Shingo Baba; Daniel Chatzifotiadis; Behnaz Goudarzi; Oleg Teytelbaum; Karen M Horton; Ihab Kamel; Katarzyna J Macura; Hua-Ling Tsai; Jeanne Kowalski; Richard L Wahl
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

7.  Impact of total lesion glycolysis measured by 18F-FDG-PET/CT on overall survival and distant metastasis in hypopharyngeal cancer.

Authors:  Hidenori Suzuki; Masami Nishio; Hayao Nakanishi; Nobuhiro Hanai; Hitoshi Hirakawa; Takeshi Kodaira; Tsuneo Tamaki; Yasuhisa Hasegawa
Journal:  Oncol Lett       Date:  2016-06-23       Impact factor: 2.967

Review 8.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

9.  TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.

Authors:  Kung-Chu Ho; Yu-Hua Dean Fang; Hsiao-Wen Chung; Yuan-Chang Liu; John Wen-Cheng Chang; Ming-Mo Hou; Cheng-Ta Yang; Nai-Ming Cheng; Tzu-Pei Su; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-03       Impact factor: 9.236

10.  Prognostic value of total lesion glycolysis on preoperative 18F-FDG PET/CT in patients with uterine carcinosarcoma.

Authors:  Jeong-Won Lee; Eun Jin Heo; Seung Hwan Moon; Hyunjong Lee; Gi Jeong Cheon; Maria Lee; Hee Seung Kim; Hyun Hoon Chung
Journal:  Eur Radiol       Date:  2016-02-16       Impact factor: 5.315
View more
  8 in total

1.  PET/CT-Based Response Evaluation in Cancer-a Systematic Review of Design Issues.

Authors:  Oke Gerke; Karen Ehlers; Edith Motschall; Poul Flemming Høilund-Carlsen; Werner Vach
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

2.  QIN Benchmarks for Clinical Translation of Quantitative Imaging Tools.

Authors:  Keyvan Farahani; Darrell Tata; Robert J Nordstrom
Journal:  Tomography       Date:  2019-03

3.  FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond.

Authors:  Malene Grubbe Hildebrandt; Jeppe Faurholdt Lauridsen; Marianne Vogsen; Jorun Holm; Mie Holm Vilstrup; Poul-Erik Braad; Oke Gerke; Mads Thomassen; Marianne Ewertz; Poul Flemming Høilund-Carlsen
Journal:  Cancers (Basel)       Date:  2019-08-15       Impact factor: 6.639

4.  FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST.

Authors:  Marianne Vogsen; Jakob Lykke Bülow; Lasse Ljungstrøm; Hjalte Rasmus Oltmann; Tural Asgharzadeh Alamdari; Mohammad Naghavi-Behzad; Poul-Erik Braad; Oke Gerke; Malene Grubbe Hildebrandt
Journal:  Diagnostics (Basel)       Date:  2021-04-19

5.  Change of Apoptosis and Glucose Metabolism in Lung Cancer Xenografts during Cytotoxic and Anti-Angiogenic Therapy Assessed by Annexin V Based Optical Imaging and 18F-FDG-PET/CT.

Authors:  Jasmin Gross; Karin Palmowski; Dennis Doleschel; Anne Rix; Felix Gremse; Frederic Verburg; Felix M Mottaghy; Fabian Kiessling; Wiltrud Lederle; Moritz Palmowski
Journal:  Contrast Media Mol Imaging       Date:  2021-04-10       Impact factor: 3.161

6.  Rapid Standardized CT-Based Method to Determine Lean Body Mass SUV for PET-A Significant Improvement Over Prediction Equations.

Authors:  Terence A Riauka; Vickie E Baracos; Rebecca Reif; Freimut D Juengling; Don M Robinson; Marguerite Wieler; Alexander J B McEwan
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

Review 7.  Thyroid cancer diagnosis in the era of precision imaging.

Authors:  Kimberley-Jane Bonjoc; Hannah Young; Susanne Warner; Thomas Gernon; Ellie Maghami; Ammar Chaudhry
Journal:  J Thorac Dis       Date:  2020-09       Impact factor: 2.895

8.  European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology.

Authors:  Roelof van Ewijk; Reineke A Schoot; Monika Sparber-Sauer; Simone A J Ter Horst; Nina Jehanno; Lise Borgwardt; Bart de Keizer; Johannes H M Merks; Alberto de Luca; Kieran McHugh; Thekla von Kalle; Jürgen F Schäfer; Rick R van Rijn
Journal:  Pediatr Radiol       Date:  2021-06-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.